Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The innate immune system stimulation via pattern recognition receptors, specifically focusing on the muramyl peptide pathway, involves the recognition of muramyl dipeptide (MDP) by NOD2 receptors. This interaction triggers downstream signaling cascades, leading to the activation of NF-kB and MAPK pathways, resulting in pro-inflammatory cytokine production. This pathway is crucial for early defense against pathogens but can contribute to inflammatory diseases if dysregulated. PRRs like NOD2 are localized in the cytosol, detecting intracellularly delivered MDP fragments, and activating signal transduction pathways that result in transcriptional responses and the release of pro-inflammatory cytokines and interferons. This pathway also influences subsequent adaptive immune responses and is a target for vaccine adjuvants and anti-inflammatory strategies.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Innate Immune System Stimulation via Pattern Recognition Receptors (Muramyl Peptide Pathway) (None).